Peginterferon alfa-2a
Jump to navigation
Jump to search
| Peginterferon alfa-2a | |
|---|---|
| Term | Peginterferon alfa-2a |
| Short definition | peginterferon alfa-2a - (pronounced) (Peg-IN-ter-FEER-on AL-fuh. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
peginterferon alfa-2a - (pronounced) (Peg-IN-ter-FEER-on AL-fuh. . . ) drug used to treat hepatitis C infection. It is also being studied in the treatment and prevention of cancer. It is a cytokine that is modified in the laboratory. It's a kind of biological response modifier. Also called Pegasys
External links
- Medical encyclopedia article on Peginterferon alfa-2a
- Wikipedia's article - Peginterferon alfa-2a
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski